Cisplatin Concentrating in MED1 Droplets in Vitro (IMAGE)
Caption
The molecular structure of the cancer drug cisplatin causes it to concentrate in tiny non-membrane bound organelles called condensates held together by the protein MED1. By altering other drugs to concentrate in specific condensates, drug developers may be able to improve targeting efficacy in future.
Credit
Isaac Klein, Whitehead Institute
Usage Restrictions
With permission of the authors.
License
Licensed content